Chemoinformaics analysis of 3-METHYLELLAGIC ACID 8-RHAMNOSIDE
| Molecular Weight | 462.363 | nRot | 3 |
| Heavy Atom Molecular Weight | 444.219 | nRig | 27 |
| Exact Molecular Weight | 462.08 | nRing | 5 |
| Solubility: LogS | -4.42 | nHRing | 3 |
| Solubility: LogP | -0.12 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 4 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 51 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 33 | No. of Aromatic Carbocycles | 2 |
| nHetero | 12 | No. of Aromatic Hetero Cycles | 2 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 12 | No. of Arom Bond | 19 |
| nHA | 12 | APOL | 56.6963 |
| nHD | 5 | BPOL | 28.4737 |
| QED | 0.204 |
| Synth | 4.33 |
| Natural Product Likeliness | 1.761 |
| NR-PPAR-gamma | 0.889 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.997 |
| HIA | 0.758 |
| CACO-2 | -6.183 |
| MDCK | 0.0000316 |
| BBB | 0.022 |
| PPB | 0.734625 |
| VDSS | 0.986 |
| FU | 0.288797 |
| CYP1A2-inh | 0.1 |
| CYP1A2-sub | 0.826 |
| CYP2c19-inh | 0.015 |
| CYP2c19-sub | 0.097 |
| CYP2c9-inh | 0.017 |
| CYP2c9-sub | 0.481 |
| CYP2d6-inh | 0.01 |
| CYP2d6-sub | 0.158 |
| CYP3a4-inh | 0.063 |
| CYP3a4-sub | 0.015 |
| CL | 2.003 |
| T12 | 0.487 |
| hERG | 0.002 |
| Ames | 0.363 |
| ROA | 0.124 |
| SkinSen | 0.142 |
| Carcinogencity | 0.049 |
| EI | 0.014 |
| Respiratory | 0.049 |
| NR-Aromatase | 0.674 |
| Antiviral | Yes |
| Prediction | 0.769444 |